Adaptive Launches T-Detect Test for the Detection of Early Lyme Disease
Shots:
- The company launched T-Detect Lyme test which detects an immune response by using the body’s unique T-cell response to disease-associated Ags for early LD in adult patients & helps to reduce the time required for an accurate diagnosis
- The T-Detect Lyme showed greater sensitivity than serology. In a clinical validation study, the T-cell test was more accurate than leading Ab tests with a specificity of ~99% & 1.5+ times greater sensitivity than STTT in patients with a bullseye rash (54% vs 30%) while in a separate study, 3 times greater sensitivity than STTT in the first 4 days after symptoms appeared (44% vs 14%)
- T-Detect Lyme will aid in scaling clinical operations to support the T-Detect portfolio including testing for autoimmune disorders
Ref: GlobalNewswire | Image: Adaptive
Click here to read the full press release
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
